Withdrawal of drugs

Type E withdrawal of drug resulting in adverse effects. 

To avoid the occurrence of ADRs in the future, specific trials to detect them should therefore be conducted before an NCE is launched on the market. Before this can be done, however, the major reasons leading to the withdrawal of drugs and termination of NCE-to-drug development should be identified and analyzed. 

Table 1.1 summarizes the reasons for the withdrawal of drugs in the past 14 years. Figure 1.3 shows the percentage of substances withdrawn for toxicity reasons and illustrates the toxicity profile of these drugs. 

Withdrawal of drug for hair loss leads to reversal within 12 mo... 

Anorexia, nausea, vomiting, headache, oligospermia (generally reversed by withdrawal of drug)... 

Transaminase elevation is the most common reason for withdrawal of drug (8%) monitor ALT qwk for first 18 wk, then decrease to q3 mo when dose is increased, monitor qwk for 6 wk... 

Some drugs are more easily withdrawn than others. In general, withdrawal of anti-absence drugs is easier than withdrawal of drugs needed for partial or generalized tonic-clonic seizures. Barbiturates and benzodiazepines are the most difficult to discontinue weeks or months may be required, with very gradual dosage decrements, to accomplish their complete outpatient removal. 

Methylphenidate, Transdermal (Daytrana) [Cll] [CNS Stimulant] WARNING w/ Hx of drug or alcohol dependence chronic use can lead to dependence or psychotic behavior observe closely during withdrawal of drug Uses ADHD in children 6-12 y Action CNS stimulant Dose Peds. 

Toxicity is a major cause for the withdrawal of drugs from the market and it is a major concern for pharmaceutical researchers. Reactive metabolism is certainly a very hot topic within the whole approach to drug metabolism. The downstream consequences of not identifying reactive metabolites may be financially catastrophic. There is an increasing drive to have early prediction of the metabolic fate and interactions of candidate drug molecules. Factors such as metabolic stability, toxic metabolite production, and P450 inhibition and induction are all routinely monitored to prevent compounds with poor pharmacokinetic properties from progressing forward onto clinical trials. 

The exception is the NDA/ANDA Postmarketing Study Reports, which are evolving and likely to become more structured and more closely scrutinized. Once those new guidelines are released, strict adherence to then-requirements will be mandatory, at the ultimate risk of a withdrawing of drug approval. 

The treatment of adverse effects of corticosteroids includes symptomatic management and dose tapering on slow withdrawal of drug. Sudden withdrawal of corticosteroids may cause adrenocortical insufficiency and may lead to death. Gradual withdrawal of corticosteroids is advisable, and supplementary corticosteroid therapy should be provided for the patient with a history of corticosteroid withdrawal. 

Drugs are a cause of disease. Withdrawal of drugs, if abrupt, can cause disease, e.g. benzodiazepines, antiepilepsy drugs. 

For discussion of abrupt withdrawal of drugs in general see page 119. Drug dependence is characterised by ... 

A cholinergic crisis should be treated by withdrawing all anticholinesterase medication, mechanical ventilation if required, and atropine i.v. for muscarinic effects of the overdose. The neuromuscular block is a nicotinic effect and will be unchanged by atropine. A resistant myasthenic crisis may be treated by withdrawal of drugs and mechanical ventilation for a few days. Plasmapheresis or immimoglobulin i.v. may be beneficial by removing antireceptor antibodies (see above). 

Sedative Hynotlcs - Sleep laboratory studies with benzodiazepines have defined the phenomenon of "rebound insomnia" ich occurs on abrupt withdrawal of drug. This phenomenon seems to be associated only with the short-acting triazolam (9a), flunltrazepam (lb) and nitrazepam (Ik) but not with the longer acting flurazepam ( ) or diazepam (la). 

Drug-induced autoimmune diseases, autoimmune-like disorders, and hypersensitivity reactions are a major concern and have caused the withdrawal of drugs from the market or restriction of their use. 

Evidence does not exclude the participation of psychogenic factors in the modification of the opiate abstinence syndrome (6). The reaction of the subject to his discomfort and to the meaning of withdrawal of drugs certainly contributes to the total picture of abstinence. Addicts with the same degree of physical habit react to the discomfort of withdrawal with widely different degrees of mental intensity. The hypothesis that withdrawal symptoms are entirely psychic is not tenable in view of the definite abstinence syndromes which have been produced in various lower animals and in view of the work of Wilder with chronic spinal and decorticated dogs. Wikler s results indicate that some components of physical dependence still develop under conditions where they can have no symbolic significance for the animal. These components are definitely nonmental (noncerebral). 

Figure 13.1 Reasons for withdrawal of drugs from development from 1964-1985.

---